Tullie Sebastian, Michell Andrew, Reid Alex W N
Department of Plastic Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.
J Hand Surg Asian Pac Vol. 2022 Dec;27(6):1035-1037. doi: 10.1142/S242483552272050X. Epub 2022 Dec 1.
Coronavirus disease 2019 (COVID-19) continues to pose significant health challenges, with insights into long-term disease sequelae emerging. The post-viral effects resulting from COVID-19 are being investigated and 'long COVID-19' is now a recognised phenomenon. As part of the spectrum of comorbidities, acute-onset neuropathy is associated with infection. The public health response aimed at limiting morbidity and mortality is rooted in vaccination programmes. With the extensive roll-out of novel vaccinations, there has been careful monitoring of temporally associated health problems. Some of the documented associations include neuropathy and entrapment neuropathies. This case report details a patient presenting with bilateral carpal tunnel syndrome (CTS) post their second dose of AZD1222 (ChAdOx1 nCoV-19) vaccination. Though we do not claim causality, the emerging post-vaccination immune-mediated effects may ultimately be proven to include neuropathy exacerbation. Meticulous recording of such associations is required as it is of great relevance to the hand surgeon managing CTS. Level V (Therapeutic).
2019冠状病毒病(COVID-19)继续构成重大的健康挑战,人们对其长期疾病后遗症的认识也在不断深入。COVID-19引发的病毒后效应正在接受研究,“长期COVID-19”现已成为一种公认的现象。作为合并症谱的一部分,急性起病的神经病变与感染有关。旨在降低发病率和死亡率的公共卫生应对措施以疫苗接种计划为基础。随着新型疫苗的广泛推广,人们一直在密切监测与之相关的健康问题。一些已记录的关联包括神经病变和卡压性神经病变。本病例报告详细介绍了一名患者在接种第二剂AZD1222(ChAdOx1 nCoV-19)疫苗后出现双侧腕管综合征(CTS)的情况。尽管我们并不认定存在因果关系,但新出现的疫苗接种后免疫介导效应最终可能被证明包括神经病变加重。由于这与手外科医生治疗CTS密切相关,因此需要对此类关联进行细致记录。V级(治疗性)。